Dogan
VC Fund
Fukuoka, Japan
Dogan is a VC fund in Fukuoka focused on Health Care and Medical. an is a professional group that provides corporate investment and advice to revitalize the local economy.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
- Fund size:
- $1.2M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Dogan invests in
Stages Dogan invests in
Countries Dogan invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $369k–$9.3M
- Corporate Round
- $196k–$896k
Investment Focus
Industry
- Health Care 3 (30%)
- Medical 2 (20%)
- Automotive 2 (20%)
- Information Technology 2 (20%)
- Nursing and Residential Care 2 (20%)
Stage
- Seed 3 (30%)
- Funding Round 3 (30%)
- Corporate Round 2 (20%)
- Series A 1 (10%)
- Venture - Series Unknown 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Daisuke Mori
Founder and CEO
|
Founder and CEO | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AZAPA
|
AZAPA engages in Automotive, Energy, Info Tech, Communication & Technology, and R & D business. It realizes renewable energy, social networks for energy optimization, and new possibilities and communication technologies through mobility management, from developed markets. It aims to build peace and abundance with advanced technology andideas to the BOP market.It was founded in 2008 and is headquartered in Nagoya, Aichi Prefecture, Japan. | Jun 29, 2026 | |
KG Motors
|
KG Motors is an automotive firm that manufactures electric vehicles that can be moved comfortably and safely by one person. | $5.3M / Series A / May 13, 2025 | |
AdipoSeeds
|
AdipoSeeds, though a novel technology, creates platelets from mesenchymal stem cells without a complex and costly gene transfer. It aims to invent new blood supply system to solve the shortage of platelets in the world, and to create a future where a platelet-related treatment will be cheaply and safely provided. | $3.8M / Venture - Series Unknown / Oct 16, 2020 | |
KabuK Style
|
KabuK Style provides services that combines co -working spaces, accommodation facilities and cafes.Our service will be started from Nagasaki and We aim to expand the services all over the world. | $9.3M / Seed / Mar 27, 2020 | |
|
KabuK Style
|
KabuK Style provides services that combines co -working spaces, accommodation facilities and cafes.Our service will be started from Nagasaki and We aim to expand the services all over the world. | $896.1K / Corporate Round / Apr 26, 2019 | |
Green Card
|
Green Card s a company in Fukuoka that runs Junior Soccer NEWS and youth soccer cheering teams. | $369.4K / Seed / Sep 28, 2018 | |
fukushi-soft
|
fukushi-soft is a company that creates software for nurses. They offer life plan support, a disability job change service for welfare workers, a social skills and education classroom, an IT X industry classroom, a developing disability portal site, an employment information site for individuals with disabilities, and a career support service. | $195.5K / Corporate Round / Sep 16, 2016 | |
SkyDisc
|
SkyDisk provides one-stop services that are necessary to make it easier to use the IoT service. Their mission is to solve business problems by visualizing data through sensors and analysis. | $855.6K / Seed / Jan 17, 2016 | |
Hyuga Primary Care
|
Hyuga Primary Care specializes in dispensing pharmacy and home care support businesses. | Jan 01, 2015 | |
Healios
|
Healios aims to commercialize the world’s first pharmaceutical hiPSC derived RPE cell transplantation for treatment of AMD in collaboration with RIKEN, one of the leading research institutes in Japan. The goal of this therapy is to promote the regeneration of retinal function and, consequently, to improve visual function in those affected withretinal degenerative diseases.The significance of the total raised capital fortifies the company’s momentum in the development of therapeutics utilizing the Nobel Prize-winning hiPSC technology and attests its uncompromising commitment to making groundbreaking strides in the field of regenerative medicine. | $425.2M / Oct 08, 2013 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Dogan invest in?
Dogan invests primarily in Health Care, Medical and Automotive startups, most often at Seed and Funding Round stage. Most of the 10 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Dogan's check size?
Dogan typically joins rounds of $369k–$9.3M at Seed and $196k–$896k at Corporate Round. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Dogan participates in.
How do I contact Dogan?
Public channels for Dogan include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Dogan?
The team at Dogan includes Daisuke Mori (Founder and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
